• Almeida da Silva PE, Osorio M, Reinhardt MC, de Souza Fonseca L & Dellagostin OA (2001) Drug resistance of strains of Mycobacterium tuberculosis isolated in Brazil. Microbes and Infection 13, 11111113.
  • Becerra MC, Freeman J, Bayona J et al. (2000) Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease 4, 108114.
  • Campos PE, Suarez PG, Sanchez J et al. (2003) Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerging Infectious Diseases 9, 15711578.
  • Espinal MA, Laszlo A, Simonsen L et al. (2001) Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. New England Journal of Medicine 344, 12941303.
  • Evans KD, Nakasone AS, Sutherland PA, de la Maza LM & Peterson EM (1992) Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinium-ester-labeled DNA probes. Journal of Clinical Microbiology 30, 24272431.
  • Laserson KF, Osorio L, Sheppard JD et al. (1998) Clinical and programmatic mismanagement rather than community outbreak as the cause of chronic, drug-resistant tuberculosis in Buenaventura, Colombia, 1998. International Journal of Tuberculosis and Lung Disease 4, 673683.
  • Mertz BL, Douce RW & Brito N (2000) Anti-tuberculosis drug resistance in two clinics in Ecuador. International Journal of Tuberculosis and Lung Disease 4, 115117.
  • Mitnick C, Bayona J, Palacios E et al. (2003) Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of Medicine 348, 119128.
  • Moore DA, Mendoza D, Gilman RH et al. (2004) Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. Journal of Clinical Microbiology 42, 44324437.
  • Mukherjee JS, Rich ML, Socci AR et al. (2004) Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 363, 474481.
  • Pelly T, Moore DA, Gilman R & Evans C (2004) Recent tuberculosis advances in Latin America. Current Opinion in Infectious Diseases 17, 397403.
  • Richter E, Weizenegger M, Rusch-Gerdes S & Niemann S (2003) Evaluation of genotype MTBC assay for differentiation of clinical Mycobacterium tuberculosis complex isolates. Journal of Clinical Microbiology 41, 26722675.
  • Roth A, Reischl U, Streubel A et al. (2000) Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases. Journal of Clinical Microbiology 38, 10941104.
  • Rusch-Gerdes S, Domehl C, Nardi G, Gismondo MR, Welscher HM & Pfyffer GE (1999) Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. Journal of Clinical Microbiology 37, 4548.
  • Timperi R, Han LL, Sloutsky A et al. (2005) Drug resistance profiles of Mycobacterium tuberculosis isolates: five years’ experience and insight into treatment strategies for MDR-TB in Lima, Peru. International Journal of Tuberculosis and Lung Disease 9, 175180.
  • Wayne LG (1974) Simple pyrazinamidase and urease tests for routine identification of mycobacteria. American Review of Respiratory Disease 109, 147151.
  • WHO (2005) WHO Report 2005: Global Tuberculosis Control – Surveillance, Planning, Financing. .